Reuters quoted an unnamed European official as saying that the European Commission is seeking the consent of member states to start negotiations with pharmaceutical companies Pfizer and BioNTech on the procurement of 1.8 billion doses of vaccines to be delivered in 2022 and 2023.
A spokesperson for the European Commission confirmed information about plans to purchase more doses, half of which are optional. Pfizer of the United States and BioNTech of Germany have jointly developed a new mRNA vaccine technology, and the American company Moderna also uses the same technology.
Reuters quoted an EU official who asked not to be named as saying that the European Commission had contacted a supplier of mRNA vaccines, but did not disclose which company it was. German “Daily News” reported that the European Commission will soon sign a contract to purchase another 1.8 billion doses.